Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 26:4:6189.
doi: 10.1038/srep06189.

Methadone induces testosterone suppression in patients with opioid addiction

Affiliations

Methadone induces testosterone suppression in patients with opioid addiction

Monica Bawor et al. Sci Rep. .

Abstract

Sex hormones may have a role in the pathophysiology of substance use disorders, as demonstrated by the association between testosterone and addictive behaviour in opioid dependence. Although opioid use has been found to suppress testosterone levels in men and women, the extent of this effect and how it relates to methadone treatment for opioid dependence is unclear. The present multi-centre cross-sectional study consecutively recruited 231 patients with opioid dependence from methadone clinics across Ontario, Canada between June and December of 2011. We obtained demographic details, substance use, psychiatric history, and blood and urine samples from enrolled subjects. The control group included 783 non-opioid using adults recruited from a primary care setting in Ontario, Canada. Average testosterone level in men receiving methadone treatment was significantly lower than controls. No effect of opioids including methadone on testosterone level in women was found and testosterone did not fluctuate significantly between menstrual cycle phases. In methadone patients, testosterone level was significantly associated with methadone dose in men only. We recommend that testosterone levels be checked in men prior and during methadone and other opioid therapy, in order to detect and treat testosterone deficiency associated with opioids and lead to successful methadone treatment outcomes.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Flow diagram for participants included in study.
Description: Flow of participants throughout each stage of the study and reasons for exclusion.
Figure 2
Figure 2. Methadone dose and serum total testosterone level in men.
Description: Inverse linear relationship between serum total testosterone level and methadone dose in men on methadone treatment (n = 131).
Figure 3
Figure 3. Testosterone level across menstrual cycle phases in control women.
Description: Testosterone level shows consistency across follicular and luteal cycle phases, as well as throughout menopause.

References

    1. Fischer B., Medved W., Gliksman L. & Rehm J. Illicit opiate users in Toronto: a profile of current users. Addict Res 7, 377–415 (1999).
    1. Fischer B., Rehm J., Patra J. & Cruz M. F. Changes in illicit opioid use across Canada. CMAJ 175, 1385, 10.1503/cmaj.060729 (2006). - PMC - PubMed
    1. United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Household Survey on Drug Abuse, 2000. Ann Arbor, MI: Inter-university Consortium for Political and Social Research, 10.3886/ICPSR03262.v5 (2013). Date of access: 25/02/2014.
    1. Back S. E. et al. Comparative profiles of men and women with opioid dependence: Results from a national multisite effectiveness trial. Am J Drug Alcohol Ab 37, 313–323 (2011). - PMC - PubMed
    1. Maremmani I. et al. Differential substance abuse patterns distribute according to gender in heroin addicts. J Psychoactive Drugs 42, 89–95 (2010). - PubMed

Publication types